Three US senators ask Mylan for EpiPen military reimbursements


EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S., August 24, 2016. REUTERS/Jim Bourg Three members of the U.S. Senate Judiciary Committee, ahead of a planned hearing late this month, said Mylan appears to have greatly overcharged the military for its lifesaving allergy treatment EpiPen and asked the pharmaceutical company when it plans to reimburse the Department of Defense.



from Biotech News